GHK-Cu + KPV Blend
Research Peptide | Lyophilized Powder | Batch Tested
For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.
Product Overview
GHK-Cu + KPV is a two-component research blend supplied in boxes of 10 vials. CK60 contains 50 mg GHK-Cu and 10 mg KPV per vial, totaling 60 mg. CK100 contains 100 mg GHK-Cu and 10 mg KPV per vial, totaling 110 mg; CK100 is the SKU name, not its combined component mass.
No published certificates yet.
SKU et conditionnement
Les quantités nominales correspondent à l’étiquette ; les mesures figurent dans chaque rapport de lot. Un rapport publié ne confirme pas le lot d’une future commande.
Questions sur le produit et ses documents
Comment lire la quantité et le conditionnement ?
La quantité par flacon et le nombre de flacons sont indiqués séparément dans le tableau. Le prix correspond à une boîte. Pour un mélange, la quantité peut être totale ; consultez l’étiquette et le rapport pour chaque composant.
Comment trouver le COA correspondant ?
Vérifiez le produit, le SKU et le numéro de lot. La page du lot contient les résultats, le rapport original et le lien de vérification. Contactez le support si le lot attribué n’est pas indiqué sur votre commande.
Une valeur de pureté signifie-t-elle que tous les tests sont conformes ?
Non. Identité, pureté, remplissage et endotoxines sont des mesures distinctes. Consultez chaque résultat et unité. Une valeur absente ne signifie pas conforme ; une valeur inférieure à un seuil n’est pas zéro.
Research Information
This blend pairs a copper-complexed tripeptide studied in extracellular-matrix models with KPV, a tripeptide investigated in PepT1-mediated uptake and inflammatory-signaling models. CK60 and CK100 differ in GHK-Cu content while retaining 10 mg KPV per vial. Ingredient research does not establish equivalent behavior across the two formulations.
GHK-Cu + KPV Blend Research & Studies
CK60 and CK100 composition
CK60 provides GHK-Cu 50 mg plus KPV 10 mg per vial, totaling 60 mg. CK100 provides GHK-Cu 100 mg plus KPV 10 mg per vial, totaling 110 mg. Both presentations contain 10 vials per box. CK100 is a catalog identifier and should not be interpreted as 100 mg total content.
GHK-Cu research context
GHK-Cu is glycyl-L-histidyl-L-lysine complexed with copper. Primary cell-culture research examined collagen synthesis and production of specific glycosaminoglycans in fibroblasts. These studies support matrix-biology research topics without establishing the behavior of the combined product.
KPV research context
Lys-Pro-Val, abbreviated KPV, has been investigated in intestinal epithelial and immune-cell systems for PepT1-mediated uptake and inflammatory responses. Mouse colitis studies provide additional preclinical context. These findings describe experimental models, not a demonstrated treatment application for this blend.
Comparing the two formulations
The labeled GHK-Cu:KPV mass ratio is 5:1 in CK60 and 10:1 in CK100. These are mass ratios, not molar ratios. Comparative assays should account for each component's concentration; neither the higher GHK-Cu content nor a shared ingredient list establishes a stronger biological effect.
Evidence for the combination
The references concern individual ingredients. They do not test these exact CK60 or CK100 formulations or establish a synergistic effect. Ingredient controls and appropriate assay readouts can help distinguish component-specific responses from those of the mixture.
Frequently Asked Questions
Does CK100 contain 100 mg total per vial?
No. CK100 contains 100 mg GHK-Cu plus 10 mg KPV per vial, totaling 110 mg of labeled components.
What changes between CK60 and CK100?
GHK-Cu increases from 50 mg to 100 mg per vial. KPV remains 10 mg per vial, and both SKUs are supplied as 10 vials per box.
Does this blend contain BPC-157?
No. These two SKUs contain GHK-Cu and KPV. GKP70 is a separate three-component product that also contains BPC-157.
What do the cited studies establish?
They document ingredient-level experimental findings. They do not demonstrate synergy or clinical effectiveness of the blend, which is offered for laboratory research only.
Learn more
Read research overviews, COA verification guides, and reconstitution notes in our Knowledge Hub.